MIPOL1

gene
On this page

Also known as CCDC193

Summary

MIPOL1 (mirror-image polydactyly 1, HGNC:21460) is a protein-coding gene on chromosome 14q13.3-q21.1, encoding Mirror-image polydactyly gene 1 protein (Q8TD10).

This gene encodes a coiled-coil domain-containing protein. The encoded protein may function as a tumor suppressor. A translocation that results in truncation of the protein encoded by this locus has been associated with mirror-image polydactyly, also known as Laurin-Sandrow Syndrome. Alternatively spliced transcript variants have been described.

Source: NCBI Gene 145282 — RefSeq curated summary.

At a glance

  • GWAS associations: 13
  • Clinical variants (ClinVar): 101 total
  • MANE Select transcript: NM_001388067

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:21460
Approved symbolMIPOL1
Namemirror-image polydactyly 1
Location14q13.3-q21.1
Locus typegene with protein product
StatusApproved
AliasesCCDC193
Ensembl geneENSG00000151338
Ensembl biotypeprotein_coding
OMIM606850
Entrez145282

Gene structure

Transcript identifiers

Ensembl transcripts: 63 — 49 protein_coding, 9 protein_coding_CDS_not_defined, 2 retained_intron, 2 nonsense_mediated_decay, 1 TEC

ENST00000327441, ENST00000396294, ENST00000537471, ENST00000539062, ENST00000539174, ENST00000553349, ENST00000554114, ENST00000554829, ENST00000554930, ENST00000555870, ENST00000556451, ENST00000556615, ENST00000556753, ENST00000556940, ENST00000624539, ENST00000684589, ENST00000694961, ENST00000694962, ENST00000694963, ENST00000694964, ENST00000694965, ENST00000694966, ENST00000694967, ENST00000694968, ENST00000694969, ENST00000694970, ENST00000694971, ENST00000694972, ENST00000695406, ENST00000698512, ENST00000909321, ENST00000909322, ENST00000909323, ENST00000909324, ENST00000909325, ENST00000909326, ENST00000909327, ENST00000909328, ENST00000909329, ENST00000909330, ENST00000909331, ENST00000931726, ENST00000931727, ENST00000931728, ENST00000931729, ENST00000931730, ENST00000931731, ENST00000971096, ENST00000971097, ENST00000971098, ENST00000971099, ENST00000971100, ENST00000971101, ENST00000971102, ENST00000971103, ENST00000971104, ENST00000971105, ENST00000971106, ENST00000971107, ENST00000971108, ENST00000971109, ENST00000971110, ENST00000971111

RefSeq mRNA: 13 — MANE Select: NM_001388067 NM_001195296, NM_001195297, NM_001388067, NM_001388068, NM_001388069, NM_001388070, NM_001388071, NM_001388072, NM_001388073, NM_001388074, NM_001388075, NM_001388077, NM_138731

CCDS: CCDS91866, CCDS91869, CCDS9664

Canonical transcript exons

ENST00000684589 — 13 exons

ExonStartEnd
ENSE000015245343724710337247240
ENSE000035225233726865837268793
ENSE000035309183728531837285447
ENSE000035577313730805637308089
ENSE000035581923726693837267169
ENSE000035938983730834937308519
ENSE000036398933727042037270525
ENSE000036555543724782937247907
ENSE000036599803736951737369624
ENSE000036741143742285537422949
ENSE000039170323719793737198104
ENSE000039179843754690537551259
ENSE000039632523749990837500138

Expression profiles

Bgee: expression breadth ubiquitous, 182 present calls, max score 94.19.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.5410 / max 533.4573, expressed in 1425 samples.

FANTOM5 promoters (6 alternative TSS)

Promoter IDTPM avgSamples expressed
1393063.67481240
1393083.57071170
1393070.6312285
1393050.3667206
1393040.2875129
1393180.01014

Top tissues by expression

249 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
calcaneal tendonUBERON:000370194.19gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047388.31gold quality
sural nerveUBERON:001548882.38gold quality
colonic epitheliumUBERON:000039781.87gold quality
adrenal tissueUBERON:001830380.54gold quality
left testisUBERON:000453379.97gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099179.95gold quality
tendonUBERON:000004379.87gold quality
testisUBERON:000047379.76gold quality
right testisUBERON:000453479.45gold quality
popliteal arteryUBERON:000225077.69gold quality
tibial arteryUBERON:000761077.67gold quality
ventricular zoneUBERON:000305377.58gold quality
olfactory segment of nasal mucosaUBERON:000538677.10gold quality
left ovaryUBERON:000211976.81gold quality
ectocervixUBERON:001224976.58gold quality
islet of LangerhansUBERON:000000676.57gold quality
aortaUBERON:000094776.41gold quality
stromal cell of endometriumCL:000225576.20gold quality
body of pancreasUBERON:000115076.02gold quality
cortical plateUBERON:000534375.93gold quality
pancreasUBERON:000126475.52gold quality
smooth muscle tissueUBERON:000113575.49gold quality
ascending aortaUBERON:000149675.34gold quality
endocervixUBERON:000045875.21gold quality
thoracic aortaUBERON:000151575.19gold quality
body of uterusUBERON:000985375.07gold quality
right ovaryUBERON:000211874.86gold quality
lower esophagus mucosaUBERON:003583474.66gold quality
ovaryUBERON:000099274.55gold quality

Single-cell (SCXA)

Detected in 15 experiment(s), a significant marker in 9.

ExperimentMarker?Max mean expression
E-CURD-6yes8146.92
E-GEOD-130473yes2442.31
E-GEOD-106540yes1423.96
E-CURD-97yes1079.18
E-MTAB-5061yes574.08
E-GEOD-81547yes455.17
E-MTAB-10137yes377.74
E-MTAB-7052yes338.46
E-ANND-3yes7.12
E-GEOD-150728no2985.24
E-MTAB-9067no1217.78
E-GEOD-98556no817.82
E-CURD-89no391.25
E-GEOD-76312no271.39
E-GEOD-70580no122.88

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

203 targeting MIPOL1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-3163100.0077.238605
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-656-3P100.0072.152788
HSA-MIR-6758-5P100.0066.211470
HSA-MIR-518D-5P100.0067.51979
HSA-MIR-518E-5P100.0067.66954
HSA-MIR-518F-5P100.0067.51979
HSA-MIR-519A-5P100.0067.66954
HSA-MIR-519B-5P100.0067.66954
HSA-MIR-519C-5P100.0067.66954
HSA-MIR-520C-5P100.0067.51979
HSA-MIR-522-5P100.0067.66954
HSA-MIR-523-5P100.0067.66954
HSA-MIR-526A-5P100.0067.51979
HSA-MIR-6867-5P100.0082.213464
HSA-MIR-6856-5P100.0065.471298
HSA-MIR-126-5P100.0072.713180
HSA-MIR-5692B100.0071.322622
HSA-MIR-5692C100.0071.322622
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-5692A100.0074.406850
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-428299.9975.366408
HSA-MIR-33A-5P99.9968.621055
HSA-MIR-33B-5P99.9968.581062
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-520D-5P99.9873.344883

Literature-anchored findings (GeneRIF, showing 4)

  • candidate gene for mirror-image polydactyly of hands and feet anomaly. Maps to 14q13. (PMID:11954550)
  • Study provides compelling evidence that chromosome 14 harbors tumor suppressor genes associated with NPC and that a candidate gene, MIPOL1, is associated with tumor development. (PMID:19667180)
  • To date, at least ten loci and four non-syndromic polydactyly-causing genes, including the GLI3 gene, the ZNF141 gene, the MIPOL1 gene and the PITX1 gene, have been identified. (Review) (PMID:26515020)
  • Functional characterization of a candidate tumor suppressor gene, Mirror Image Polydactyly 1, in nasopharyngeal carcinoma. (PMID:31609475)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriomipol1ENSDARG00000104845
mus_musculusMipol1ENSMUSG00000047022
rattus_norvegicusMipol1ENSRNOG00000009151

Protein

Protein identifiers

Mirror-image polydactyly gene 1 proteinQ8TD10 (reviewed: Q8TD10)

All UniProt accessions (15): A0A8Q3SHM7, A0A8Q3SHT3, A0A8Q3SHU0, A0A8Q3SHU5, A0A8Q3SHV0, A0A8Q3SHV2, A0A8Q3SHY7, A0A8Q3SI06, A0A8Z5CCZ9, Q8TD10, G3V2C4, G3V3K8, G3V5R6, G5EA54, Q49AL5

UniProt curated annotations — full annotation on UniProt →

Tissue specificity. Expressed very weakly in heart, liver, skeletal muscle, kidney, pancreas and fetal kidney. Not detected in brain, placenta and lung.

Disease relevance. A chromosomal aberration involving MIPOL1 is found in a patient with mirror-image polydactyly of hands and feet without other anomalies (MIP). Translocation t(2;14)(p23.3;q13). MIP is a very rare congenital anomaly characterized by mirror-image duplication of digits. MIP is occasionally associated with dimelia of the ulna and fibula, tibial and/or fibular hypoplasia, nasal abnormality and other malformations. Most MIP cases are sporadic, but very rare parent-child transmissions observed in familial cases suggest an autosomal mode of inheritance.

Miscellaneous. May be due to a competing acceptor splice site.

Isoforms (3)

UniProt IDNamesCanonical?
Q8TD10-11yes
Q8TD10-22
Q8TD10-33

RefSeq proteins (13): NP_001182225, NP_001182226, NP_001374996, NP_001374997, NP_001374998, NP_001374999, NP_001375000, NP_001375001, NP_001375002, NP_001375003, NP_001375004, NP_001375006, NP_620059 (=MANE)

Domains & families (InterPro)

IDNameType
IPR026175MIPOL1Family

UniProt features (9 total): splice variant 3, coiled-coil region 2, chain 1, region of interest 1, compositionally biased region 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8TD10-F177.510.53

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 102 (showing top): RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497, ACATTCC_MIR1_MIR206, AACTTT_UNKNOWN, NOUZOVA_TRETINOIN_AND_H4_ACETYLATION, chr14q13, ACACTCC_MIR122A, MODULE_342, GEORGES_TARGETS_OF_MIR192_AND_MIR215, GCNP_SHH_UP_EARLY.V1_DN, GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN, CBX7_TARGET_GENES, COBLL1_TARGET_GENES, NFE2L1_TARGET_GENES

GO Biological Process (0):

GO Molecular Function (2): identical protein binding (GO:0042802), protein binding (GO:0005515)

GO Cellular Component (1): nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
protein binding1
binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

754 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
MIPOL1SLC25A21Q9BQT8731
MIPOL1PITX2Q99697657
MIPOL1PITX1P78337651
MIPOL1CARD14Q9BXL6548
MIPOL1ETV1P50549525
MIPOL1ZNF141Q15928515
MIPOL1FOXC1Q12948494
MIPOL1RUSC2Q8N2Y8483
MIPOL1DLX2Q07687469
MIPOL1SLC45A3Q96JT2456
MIPOL1ALX3O95076455
MIPOL1SMIM23A6NLE4448
MIPOL1IGFBPL1Q8WX77442
MIPOL1IQCEQ6IPM2431
MIPOL1OTPQ5XKR4424

IntAct

305 interactions, top by confidence:

ABTypeScore
SSX3MIPOL1psi-mi:“MI:0915”(physical association)0.780
MIPOL1SSX3psi-mi:“MI:0915”(physical association)0.780
MIPOL1PRPF31psi-mi:“MI:0915”(physical association)0.720
CCT3MIPOL1psi-mi:“MI:0915”(physical association)0.720
MIPOL1UBE2Kpsi-mi:“MI:0915”(physical association)0.720
MIPOL1BYSLpsi-mi:“MI:0915”(physical association)0.720
FAM161AMIPOL1psi-mi:“MI:0915”(physical association)0.720
MIPOL1ZGPATpsi-mi:“MI:0915”(physical association)0.720
MIPOL1MAGEA6psi-mi:“MI:0915”(physical association)0.720
TTC12MIPOL1psi-mi:“MI:0915”(physical association)0.720
SMARCE1MIPOL1psi-mi:“MI:0915”(physical association)0.720
SCNM1MIPOL1psi-mi:“MI:0915”(physical association)0.720
ENKD1MIPOL1psi-mi:“MI:0915”(physical association)0.720
PRPF31MIPOL1psi-mi:“MI:0915”(physical association)0.720
MIPOL1CCT3psi-mi:“MI:0915”(physical association)0.720
UBE2KMIPOL1psi-mi:“MI:0915”(physical association)0.720
BYSLMIPOL1psi-mi:“MI:0915”(physical association)0.720
MAGEA6MIPOL1psi-mi:“MI:0915”(physical association)0.720
MIPOL1TTC12psi-mi:“MI:0915”(physical association)0.720
MIPOL1SMARCE1psi-mi:“MI:0915”(physical association)0.720

BioGRID (128): MIPOL1 (Two-hybrid), MIPOL1 (Two-hybrid), MIPOL1 (Two-hybrid), MIPOL1 (Two-hybrid), MIPOL1 (Two-hybrid), MIPOL1 (Two-hybrid), MIPOL1 (Two-hybrid), MIPOL1 (Two-hybrid), MIPOL1 (Two-hybrid), MIPOL1 (Two-hybrid), MIPOL1 (Two-hybrid), MIPOL1 (Two-hybrid), MIPOL1 (Two-hybrid), MIPOL1 (Two-hybrid), MIPOL1 (Two-hybrid)

ESM2 similar proteins: A0JMQ7, A2AM05, A2AUM9, A6PWD2, A7MD70, B1AJZ9, O35550, O35551, O75330, O94986, P0CB05, Q03410, Q05D60, Q15276, Q15431, Q17QT2, Q2KJE0, Q3UKC1, Q3UPP8, Q498G2, Q4KLY0, Q4R703, Q4R7H3, Q5NVN6, Q5PR68, Q5R4U3, Q5U3Z6, Q5VU43, Q5ZJA3, Q62209, Q66HA4, Q66KE8, Q69ZB0, Q6NRC9, Q6P3P1, Q6TFL3, Q70FJ1, Q80UF4, Q80Z25, Q86SQ7

Diamond homologs: Q8TD10, Q9D9F8

SIGNOR signaling

3 interactions.

AEffectBMechanism
MIPOL1“up-regulates activity”RHOBbinding
MIPOL1“down-regulates activity”AKT
MIPOL1“down-regulates activity”RELA

Disease & clinical

Clinical variants and AI predictions

ClinVar

101 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance74
Likely benign9
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

5207 predictions. Top by Δscore:

VariantEffectΔscore
14:37240570:G:GGdonor_gain1.0000
14:37266933:TACA:Tacceptor_loss1.0000
14:37266934:ACAG:Aacceptor_loss1.0000
14:37266936:A:ACacceptor_loss1.0000
14:37266937:GA:Gacceptor_gain1.0000
14:37266937:GAC:Gacceptor_gain1.0000
14:37266937:GACAT:Gacceptor_gain1.0000
14:37267170:G:GGdonor_gain1.0000
14:37267750:T:Gacceptor_gain1.0000
14:37268656:A:AGacceptor_gain1.0000
14:37268657:G:GGacceptor_gain1.0000
14:37268657:GC:Gacceptor_gain1.0000
14:37268657:GCGTT:Gacceptor_gain1.0000
14:37268789:AAAAG:Adonor_loss1.0000
14:37268790:AAAG:Adonor_loss1.0000
14:37268791:AAG:Adonor_loss1.0000
14:37268792:AGGT:Adonor_loss1.0000
14:37268793:GGTAT:Gdonor_loss1.0000
14:37268794:GTATA:Gdonor_loss1.0000
14:37268795:T:Adonor_loss1.0000
14:37268805:A:Tdonor_gain1.0000
14:37285312:T:TAacceptor_gain1.0000
14:37285316:A:AGacceptor_gain1.0000
14:37285317:G:GGacceptor_gain1.0000
14:37285317:GCT:Gacceptor_gain1.0000
14:37285431:G:GTdonor_gain1.0000
14:37285443:AAAGT:Adonor_gain1.0000
14:37285444:AAGT:Adonor_gain1.0000
14:37285446:GT:Gdonor_gain1.0000
14:37285448:G:GGdonor_gain1.0000

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000003634 (14:37362931 A>G), RS1000020282 (14:37581007 A>G), RS1000020864 (14:37334908 T>C,G), RS1000027370 (14:37422966 C>T), RS1000044800 (14:37581366 C>T), RS1000046242 (14:37487829 C>A,T), RS1000058250 (14:37490704 G>C,T), RS1000069497 (14:37355290 G>A,C,T), RS1000075454 (14:37277770 T>A), RS1000078183 (14:37406822 T>C), RS1000078473 (14:37487543 A>C,T), RS1000084733 (14:37543429 C>A,G), RS1000092065 (14:37235395 T>C), RS1000097018 (14:37575957 A>AG), RS1000100258 (14:37222301 C>A)

Disease associations

OMIM: gene MIM:606850 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

13 associations (top):

StudyTraitp-value
GCST002981_5Longitudinal alcohol consumption1.000000e-06
GCST003995_9Tonsillectomy8.000000e-13
GCST004602_177Mean corpuscular volume3.000000e-14
GCST004630_198Mean corpuscular hemoglobin8.000000e-15
GCST005014_96Tonsillectomy8.000000e-13
GCST005580_81Intraocular pressure2.000000e-11
GCST005580_88Intraocular pressure4.000000e-11
GCST008058_276Estimated glomerular filtration rate2.000000e-07
GCST009325_15Parkinson’s disease or first degree relation to individual with Parkinson’s disease4.000000e-08
GCST009391_424Metabolite levels7.000000e-06
GCST90002382_223Eosinophil percentage of white cells6.000000e-11
GCST90002396_560Mean reticulocyte volume1.000000e-40
GCST90002403_504Red blood cell count1.000000e-15

EFO canonical traits (8, from GWAS)

EFO IDTrait name
EFO:0007645longitudinal alcohol consumption measurement
EFO:0007924tonsillectomy risk measurement
EFO:0004527mean corpuscular hemoglobin
EFO:0004695intraocular pressure measurement
EFO:0010388phosphatidylcholine 38:6 measurement
EFO:0007991eosinophil percentage of leukocytes
EFO:0010701mean reticulocyte volume
EFO:0004305erythrocyte count

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

25 total (human), top 25 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyrenedecreases expression, decreases methylation3
aristolochic acid Idecreases expression1
dicrotophosdecreases expression1
trichostatin Aincreases expression1
sodium arseniteincreases abundance, increases expression1
cobaltous chloridedecreases expression1
potassium chromate(VI)affects cotreatment, decreases expression1
epigallocatechin gallateaffects cotreatment, decreases expression1
phenethyl isothiocyanateaffects binding1
jinfukangaffects cotreatment, decreases expression1
MT19c compoundincreases expression1
Temozolomideincreases expression1
Leflunomideincreases expression1
Arsenicincreases abundance, increases expression1
Cisplatinaffects cotreatment, decreases expression1
Clorgylineincreases expression1
Endosulfandecreases expression1
Methotrexateincreases expression1
Quercetindecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Urethaneincreases expression1
Valproic Acidaffects expression1
Vanadatesdecreases expression1
Cyclosporineincreases expression1
Aflatoxin M1decreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.